Cellectis Stock Rises 4% Against a CAC 40 Weighed Down by Iran
The biotech company's stock is among the few showing significant gains this Monday, while the CAC 40 drops by 0.87% during the session. Cellectis has rebounded by more than 4% from its last close, reaching 3.316 euros, in a market environment weakened by geopolitical tensions in the Middle East.
Current Session Performance
During the session, Cellectis has risen by 4.02% to 3.316 euros, bringing its weekly performance to +6.8%. This surge comes after several challenging weeks: over three months, the stock is still down by 8.52%. However, the outlook has completely reversed over the year, with a dramatic increase of 154.7% since spring 2025, indicating a significant transformation in the company's valuation.
This bullish movement occurs while the Parisian healthcare sector is in the red. Sanofi is down by 1.21% and UCB loses 0.91% during the session. The CAC 40, meanwhile, is down by 0.87% at 8,188 points, weighed down by the announcement of a U.S. naval blockade against Iran and the surge in oil prices above 100 dollars a barrel. Cellectis' rebound thus appears decoupled from the general trend, a behavior consistent with its negative beta of -0.62, indicating low sensitivity to overall market movements.
Technical Analysis
Technically, Cellectis' stock price at 3.316 euros is positioned in the middle of the Bollinger Bands (upper boundary at 3.65 euros, lower boundary at 2.90 euros), placing the stock in a neutral zone without excessive bullish or bearish trends. The 50-day moving average, set at 3.36 euros, remains slightly above the current price: a sustained crossing of this threshold would signal a strengthening of the trend.
The RSI, at 35, is approaching the traditionally oversold zone located below 30 points, indicating that the selling pressure from recent weeks has not completely dissipated despite the day's rebound. The technical support identified at 2.93 euros, close to the 200-day moving average (2.94 euros), has so far played its role as a floor. The key resistance is at 3.63 euros, a level almost aligned with the upper Bollinger Band, whose crossing could mark a more lasting change in dynamics.
